The publisher Springer is seeking applications and nominations for the position of the Editor-in-Chief for the European Journal of Hybrid Imaging (EJHI). The journal enjoys a fruitful partnership with the European Association of Nuclear Medicine (EANM). Details about the journal are available on the journal's website.
EJHI is a fully Open Access journal and currently dedicated to hybrid imaging applications only. Going forward, the scope of the journal will be expanded to transform EJHI into a broad scope nuclear medicine journal covering all aspects of nuclear medicine and molecular imaging including both, diagnostic and therapeutic aspects. At the same time, more space for clinical and research articles will be offered.
The journal is available in all major indexing services and received its first impact factor in 2023. The published articles created more than 100,000 downloads in 2022.
Currently, the journal publishes original research articles, brief communications on novel preliminary approaches, case reports, reviews, guidelines, editorials, and letters to the editor, published by experts from different clinical disciplines. Future article types will be fine-tuned by the Editor-in-Chief in consultation with the publisher.
The journal will be run under the leadership of one Editor-in-Chief (EIC), supported by 4-5 Section Editors and an Editorial Board nominated by the EIC in close collaboration with the publisher. The role of the EIC comprises pro-active content acquisition as well as leading and managing the peer-review process in a timely manner in close cooperation with the Section Editors, the Editorial Board, Reviewers and Authors. This includes proactive commissioning of topical collections on timely topics of interest to the international nuclear medicine and molecular imaging community. The EIC adheres to international standards of good editorial practice and the publisher’s code of conduct.
The EIC serves for an initial term of two years. The term of service for this position starts on January 1st, 2024 and expires on December 31st, 2025. A transition period at the end of 2023 would be highly desirable. The ideal candidate should have a vision on how to lead the journal, grow the published content and further increase the visibility and reputation of the journal in the international community. He/she will establish a close working relationship with his/her Section Editors. The candidate should have a broad interest and strong expertise in nuclear medicine as a whole, a high level of commitment to leading this journal and a clear idea of the pragmatic issues involved in accomplishing this mission. The EIC is expected to work closely with the global publisher Springer on all aspects of publishing.
Each interested individual is invited to submit an application via e-mail. The application should include: a succinct letter of interest and qualifications, a vision statement and short curriculum vitae. Contact for queries and applications: Sabine Ben Ghechir, Senior Publisher Journals Medicine & Life Sciences at email@example.com. Submissions should be received by October 8th, 2023.